Tag: Medicare

Medicare Advantage's Role in Addressing Healthcare Costs for Vulnerable Populations

Explore the significance of Medicare Advantage in managing healthcare expenses for seniors and people with disabilities, focusing on diabetes care and insulin affordability.

2025 Payer + Provider Summit Highlights AI, Value-Based Care, and Community Partnerships

Insights from the 2025 Payer + Provider Summit on AI-driven care, value-based models, community partnerships, and the need for stable federal policies to advance primary and preventive care.

CMS Updates Competitive Bidding Program for Durable Medical Equipment

CMS revises competitive bidding program for durable medical equipment, affecting supply contracts and patient access concerns within Medicare's medical device market.

Medicare Drug Price Negotiations Cut Costs for 15 Key Medications

New Medicare drug price negotiations reduce government costs on 15 high-spend medications, including cancer and diabetes treatments, saving $12 billion annually.

Medicare Open Enrollment 2025: Key Dates and Coverage Review Insights

Learn about the 2025 Medicare Open Enrollment Period from October 15 to December 7, including changes to prescription drug coverage and tips for beneficiaries to optimize their health plans.

UnitedHealthcare Unveils Broad 2026 Policy Updates Affecting Medicare, Medicaid, Commercial Plans

Explore UnitedHealthcare’s extensive 2026 policy and program updates for Medicare, Medicaid, and commercial health plans, including coverage expansions, referral changes, and streamlined prior authorizations.

Washington's Medicare Adopts AI-Driven Prior Authorization Pilot in 2026

Starting in 2026, Washington state will implement an AI-driven prior authorization pilot for traditional Medicare, raising new compliance and access challenges. Learn about the pilot's impact on Medicare claims processing and healthcare providers.

Medicare Drug Price Negotiations Yield 44% Savings Under Inflation Reduction Act

Medicare's Inflation Reduction Act negotiations cut prices for 15 top prescription drugs by 44%, reducing out-of-pocket costs and impacting Medicare Part D and Part B markets.

CMS to Lower Prices on 15 Major Medicare Part D Drugs by 2027

CMS announces reduced prices for 15 key Medicare Part D drugs starting in 2027, following the Inflation Reduction Act negotiations, targeting major cost savings in Medicare spending.

Medicare Open Enrollment: Assistance from SHINE Counselors to Optimize Coverage

Medicare open enrollment from Oct. 15 to Dec. 7 provides beneficiaries a chance to review and adjust their healthcare plans with support from SHINE counselors. Learn how to optimize coverage and manage costs effectively.